Navigation Links
ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
Date:4/9/2008

- ProMetic to acquire common stock held by American Red Cross, in a

cashless transaction, taking ProMetic's stake in PRDT to 77% - American Red Cross to remain involved on the Board of Directors of PRDT

MONTREAL and CAMBRIDGE, England, April 9 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announces that ProMetic has signed a Letter of Intent ("LOI") to acquire the American Red Cross' ("ARC") common stock holding in Pathogen Removal and Diagnostic Technologies Inc. ("PRDT"), the joint venture established by ProMetic and ARC in 2002 to develop and commercialize products to diagnose and reduce pathogens in blood, blood derivatives, biopharmaceuticals and other biological products.

The transaction contemplated by the LOI is a natural progression following commercialization of the P-Capt(R) filter and the prion reduction resin that was fully licenced to ProMetic.

The terms of the LOI provide for an ongoing royalty stream to ARC based on income derived from PRDT technology. In exchange, ProMetic will raise its ownership position in PRDT to 77% by acquiring ARC's 51% stake in PRDT. The remaining 23% will continue to be held by the academic co-founders. ARC will continue to hold its preferred stock and maintain representation on the Board of Directors.

"With the commercialization of the PRDT technology well underway and the projected strong market demand for this technology, ProMetic's increased stake in PRDT to 77% will allow for the revenues derived from the technology to be fully consolidated into ProMetic's financial results," stated Mr. Bruce Pritchard, ProMetic's Vice President of Corporate Development. Mr. Pritchard added: "The structure of this deal is beneficial to both parties, allowing ARC to share in the ongoing success of the jointly developed technology, whilst not requiring a cash payment by ProMetic".

"ARC has played a pivotal role within PRDT in advancing the technology to a
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Prometic to present at the American Chemical Society
2. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
3. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
4. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
5. ProMetic provides business update - Over $35 million worth of business secured in January
6. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
7. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
8. PerOs obtains USDA Establishment and Product Licenses for its oral vaccine formulations
9. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
10. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
11. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...nty of Britain,s most,innovative technology compan...t the fifth annual SETsquared Partnership Showcase...George Street, London, from 8am on,Thursday, Octob...nnovators,in electronics, information technology, ...l give 10-minute presentations to an audience of,a...
(Date:10/10/2008)...da Pharmaceutical Company,Limited ("Takeda") today...ment Center, Inc., a wholly owned United States (U...S. Food and Drug Administration (FDA) will,not be ...Drug Application,(NDA) by the Prescription Drug Us... our most recent discussion with the FDA, it indic...
(Date:10/9/2008)...Pairing traditional quality,tools with innovations...g,are helping organizations reduce waste, meet cus...today,s market. At How Process Improvement Leaders...ality excellence,conference hosted by Best Practic...from leading companies shared results from recent ...
(Date:10/9/2008)...oss Life Sciences Industry -, ROCKLAND, Mass., Oc...e,of Merck KGaA, Darmstadt, Germany, announced tod... top employer in the biotechnology and,pharmaceuti... employers,across the life sciences., "We are hon...EMD Serono,as a leading place to work," said Bernh...
Breaking Biology Technology:Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 2Creators of Britain's Innovation Economy to Showcase the Technologies of the Future at the Fifth SETsquared Partnership Showcase 2008 3FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes 2Six Sigma and Social Media: Tools for Reducing Costs, Improving Processes 2EMD Serono Named as a Top Employer by Science Magazine 2
...ng increasing demand for technical employees, acco... resources firm Adecco . , ,In Adecco,s "Where th...f state unemployment reports, the company states t...ed a growth in technical positions in the manufact...s. , ,Scott Zorn, Adecco Technical area vice pr...
...the training of women scientists and the implement... barriers, the career path of most women scientist...t with roadblocks of bias, a sometimes chilly camp...nd work. , ,That, in short, is the conclusion of a...luding chancellors and provosts, in an analysis in...
...on protecting the U.S. food supply from terrorism ...stpone the event until spring from its original No...mposium was originally slated for Nov. 1-3 in dow...cted from the Great Lakes region, including Canada...sin Procurement Institute, is helping to plan the ...
... team announced on Sunday they have successfully c...lls, a finding that could affect some of the ethic...nues. But a University of Wisconsin-Madison profes...ercussions. , ,In an article published on the Web ...s Chad Cowan, Kevin Eggan and their colleagues at ...
Other Biology Technology:Wisconsin's tech employment shows increase, HR firm reports 2Despite gains, women still face bias in science careers 2Despite gains, women still face bias in science careers 3Despite gains, women still face bias in science careers 4Harvard advance improves stem cell research; not a medical revolution 2
(Date:10/10/2008)...ital for Special Surgery researchers have found th...women who are suffering from pregnancy complicatio...rding to a study in mice. In this autoimmune syndr...pholipids, the main components of cell membranes. ...ber issue of the Journal of Clinical Investigatio...
(Date:10/10/2008)...ya Yamanaka MD, PhD, of Kyoto University and the G...) has taken another step forward in improving the ...uced pluripotent stem (iPS) cell technology. , P... can be reprogrammed to become embryonic stem cell... four genes required to reprogram the cells, and a...
(Date:10/10/2008)..., The stickleback fish, Gasterosteus aculeatus , ... the wild, and has been a particularly useful mode...ior, life history and morphology caused by differe...gical levels from molecular and genetic to develop...the population level, it has proven far more compl...
(Date:10/10/2008)...s release is available in German . , DNA, the...rmation in all forms of life, is highly resistant ...standing the mechanism for its photostability pres...nteraction between the four chemical bases that ma...sity have succeeded in showing that DNA strands di...
Breaking Biology News(10 mins):Statins may prevent miscarriages 2Statins may prevent miscarriages 3Yamanaka eliminates viral vector in stem cell reprogramming 2Fitness in a changing world 2Fitness in a changing world 3Can genetic information be controlled by light? 2Medifast Inc Announces Acceptance for Publication of Clinical Efficacy Study 515 1Medifast Inc Announces Acceptance for Publication of Clinical Efficacy Study 515 2Negative Publicity Around PFFS Sales Practices Not Getting Through to Seniors 3686 1Quality Affordable Health Care for All 3681 1Quality Affordable Health Care for All 3681 2Quality Affordable Health Care for All 3681 3Quality Affordable Health Care for All 3681 4Quality Affordable Health Care for All 3681 5MultiVu Video Feed 3A FDA Approves DORIBAX 28TM 29 28doripenem for injection 29 for the Treatment of Complicated Intra abdominal and Complicated Urin 3676 1MultiVu Video Feed 3A FDA Approves DORIBAX 28TM 29 28doripenem for injection 29 for the Treatment of Complicated Intra abdominal and Complicated Urin 3676 2
...ost half the animal species on the planet has been...evealed new relationships between four major group... and moths are most closely related to beetles and...y to previous theory. , The findings are publi...journal Genome Research which coincides with Natur...
...about how birds evolved the ability to fly, becaus...n fitness would result from ancestral, partly evol...e debate: one postulates that flight evolved in tr... help them glide, while the other considers ancest...ed powered flight from the ground up. , An article...
...drastically reduces the infection rate of three vi...ith compromised immune systems. The findings, to b...edicine, originate from a study conducted at Baylo... Texas Children,s Hospital. , The journal has pos...unded by the National Heart, Lung, and Blood Insti...
...nvestigators at the Center for AIDS Research at Ca...long with a nationwide team of AIDS/HIV experts, s... role of measurements of the amount of HIV particl...t,s ability to fight off the disease. The study, p...the American Medical Association), indicates that ...
Other Biology News:New genetic analysis forces re-draw of insect family tree 2Protowings may have helped bird ancestors cover rough terrain 2Three-in-one virus killer prevents common, often fatal infections 2AIDS study challenges conventional treatment guidelines for HIV patients 2AIDS study challenges conventional treatment guidelines for HIV patients 3
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria
Goat polyclonal to ORC2L ( Abpromise for all tested applications). entrezGeneID: 4999 SwissProtID: Q13416
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Anti 7H6 Antigen (tight-junction associated protein Antigen) Monoclonal Antibody 7H6
Biology Products: